Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002101
Filing Date
2008-02-29
Accepted
2008-02-29 16:59:00
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183057z10-k.htm 10-K 1043457
2 EXHIBIT 10.31 a2183057zex-10_31.htm EX-10.31 8780
3 EXHIBIT 10.32 a2183057zex-10_32.htm EX-10.32 6730
4 EXHIBIT 14.1 a2183057zex-14_1.htm EX-14.1 54074
5 EXHIBIT 21.1 a2183057zex-21_1.htm EX-21.1 3913
6 EXHIBIT 23.1 a2183057zex-23_1.htm EX-23.1 2718
7 EXHIBIT 31.1 a2183057zex-31_1.htm EX-31.1 7032
8 EXHIBIT 31.2 a2183057zex-31_2.htm EX-31.2 7212
9 EXHIBIT 32.1 a2183057zex-32_1.htm EX-32.1 4072
10 EXHIBIT 32.2 a2183057zex-32_2.htm EX-32.2 4163
11 G746742.JPG g746742.jpg GRAPHIC 26669
  Complete submission text file 0001047469-08-002101.txt   1180582
Mailing Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328
Business Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328 678-341-1436
SCIELE PHARMA, INC. (Filer) CIK: 0001106773 (see all company filings)

EIN.: 582004779 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30123 | Film No.: 08656662
SIC: 2834 Pharmaceutical Preparations